AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Morningstar analysts cut fair value estimates for 37 US-listed stocks by 10% or more after Q3 earnings, exceeding the 10-year average. Five stocks saw the largest cuts, with Intellia Therapeutics' estimate slashed from $60 to $27, followed by Optimum Communications' cut from $4 to $2. Despite the cuts, four of the five stocks have 5-star Morningstar Ratings, indicating they're attractively priced for long-term investors.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet